Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Koenecke C et al. – The authors suggest that therapeutic approaches to treat GVHD should rely on nTreg, whereas the use of de novo alloantigen–induced iTreg should be handled with caution since the stability of the regulatory phenotype of the iTreg could be of major concern.


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address